| RVMDREVOLUTION MEDICINES, INC. | 2,506,570 | $243.8M |
| TNGXTango Therapeutics, Inc. | 8,000,013 | $167.4M |
| PTGXProtagonist Therapeutics, Inc | 1,414,173 | $149.1M |
| RCUSArcus Biosciences, Inc. | 3,777,798 | $81.6M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 243,883 | $80.7M |
| SRRKScholar Rock Holding Corp | 1,500,470 | $73.8M |
| GILDGILEAD SCIENCES, INC. | 500,641 | $69.8M |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 758,891 | $66.0M |
| CYTKCYTOKINETICS INC | 1,000,428 | $65.9M |
| NUVLNuvalent, Inc. | 610,459 | $62.5M |
| IRONDisc Medicine, Inc. | 958,281 | $61.3M |
| COGTCogent Biosciences, Inc. | 1,509,557 | $58.1M |
| INCYIncyte Corp. | 605,717 | $57.0M |
| REGNREGENERON PHARMACEUTICALS, INC. | 67,751 | $52.3M |
| PTCTPTC THERAPEUTICS, INC. | 744,988 | $50.8M |
| IMVTImmunovant, Inc. | 1,975,869 | $49.1M |
| ROIVRoivant Sciences Ltd. | 1,750,017 | $48.5M |
| PVLAPALVELLA THERAPEUTICS, INC. | 317,517 | $39.6M |
| APLSApellis Pharmaceuticals, Inc. | 976,175 | $39.3M |
| SLNOSOLENO THERAPEUTICS INC | 1,112,104 | $37.2M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 433,457 | $36.4M |
| TEVATeva Pharmaceutical Industries Limited | 1,163,863 | $35.1M |
| CNTACentessa Pharmaceuticals plc | 859,105 | $34.1M |
| ZVRAZEVRA THERAPEUTICS, INC. | 3,450,943 | $32.2M |
| MANEVeradermics Incorporated | 500,646 | $31.6M |
| KALVKalVista Pharmaceuticals, Inc. | 1,509,920 | $30.4M |
| NKTRNEKTAR THERAPEUTICS | 415,335 | $29.9M |
| ORKAOruka Therapeutics, Inc. | 574,882 | $28.2M |
| AXSMAxsome Therapeutics, Inc. | 162,221 | $27.4M |
| IBRXImmunityBio, Inc. | 3,447,346 | $26.4M |
| ABVXAbivax SA | 225,892 | $25.2M |
| INSMINSMED Inc | 148,453 | $24.3M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 752,308 | $24.1M |
| TGTXTG THERAPEUTICS, INC. | 715,500 | $23.8M |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 448,996 | $23.2M |
| SVRASavara Inc | 4,245,119 | $23.2M |
| BBIOBridgeBio Pharma, Inc. | 301,012 | $22.4M |
| OLMAOlema Pharmaceuticals, Inc. | 1,482,030 | $22.1M |
| APGEApogee Therapeutics, Inc. | 261,120 | $22.0M |
| EXELEXELIXIS, INC. | 485,408 | $20.8M |
| XOMAXOMA Royalty Corporation | 640,001 | $20.1M |
| MAZEMaze Therapeutics, Inc. | 650,229 | $19.4M |
| ANABANAPTYSBIO, INC | 344,256 | $19.1M |
| PCVXVaxcyte, Inc. | 274,740 | $16.0M |
| CLDXCelldex Therapeutics, Inc. | 500,127 | $15.9M |
| ORICOric Pharmaceuticals, Inc. | 1,247,515 | $15.8M |
| ACADACADIA PHARMACEUTICALS INC | 676,401 | $15.1M |
| NRIXNurix Therapeutics, Inc. | 925,444 | $14.3M |
| DFTXDefinium Therapeutics Inc. | 752,792 | $14.2M |
| OCULOCULAR THERAPEUTIX, INC | 1,667,609 | $14.1M |
| VRDNViridian Therapeutics, Inc.\DE | 700,929 | $13.7M |
| SYRESpyre Therapeutics, Inc. | 265,892 | $13.4M |
| ANNXAnnexon, Inc. | 2,337,137 | $12.9M |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 200,184 | $12.6M |
| ELVNEnliven Therapeutics, Inc. | 301,673 | $11.8M |
| ZBIOZenas BioPharma, Inc. | 590,525 | $11.5M |
| STROSUTRO BIOPHARMA, INC. | 457,441 | $11.4M |
| SABSSAB BIOTHERAPEUTICS, INC. | 2,851,791 | $10.9M |
| MRNAModerna, Inc. | 211,473 | $10.7M |
| DSGNDesign Therapeutics, Inc. | 961,501 | $10.2M |
| ABSIAbsci Corporation | 3,300,169 | $9.9M |
| VKTXViking Therapeutics, Inc. | 302,751 | $9.9M |
| IMTXImmatics N.V. | 1,000,597 | $9.8M |
| IMCRImmunocore Holdings plc | 316,762 | $9.6M |
| CTMXCytomX Therapeutics, Inc. | 2,000,825 | $9.4M |
| GPCRStructure Therapeutics Inc. | 190,808 | $9.2M |
| ABUSArbutus Biopharma Corp | 2,010,172 | $9.0M |
| TVTXTravere Therapeutics, Inc. | 302,666 | $9.0M |
| VCELVericel Corp | 271,752 | $8.7M |
| FBRXForte Biosciences, Inc. | 331,987 | $8.6M |
| UPBUpstream Bio, Inc. | 831,481 | $7.5M |
| DNLIDenali Therapeutics Inc. | 364,082 | $7.0M |
| RLAYRelay Therapeutics, Inc. | 679,342 | $6.8M |
| SRZNSurrozen Inc. | 227,848 | $6.6M |
| LRMRLarimar Therapeutics, Inc. | 1,400,850 | $6.3M |
| IRDOpus Genetics, Inc. | 1,354,030 | $6.2M |
| PGENPRECIGEN, INC. | 1,401,412 | $5.4M |
| OCSOculis Holding AG | 201,200 | $5.3M |
| SGMTSagimet Biosciences Inc. | 1,000,943 | $5.2M |
| TENXTENAX THERAPEUTICS, INC. | 323,911 | $5.2M |
| PMNProMIS Neurosciences Inc. | 395,295 | $5.0M |
| BCAXBicara Therapeutics Inc. | 232,690 | $4.6M |
| ARQTArcutis Biotherapeutics, Inc. | 195,033 | $4.6M |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 1,291,984 | $4.5M |
| CAPRCAPRICOR THERAPEUTICS, INC. | 137,655 | $4.2M |
| XFORX4 Pharmaceuticals, Inc | 1,001,095 | $4.1M |
| NUVBNuvation Bio Inc. | 960,414 | $4.1M |
| SMMTSummit Therapeutics Inc. | 214,507 | $4.1M |
| DAWNDay One Biopharmaceuticals, Inc. | 189,057 | $4.1M |
| SANASana Biotechnology, Inc. | 1,317,932 | $3.8M |
| LQDALiquidia Corp | 100,160 | $3.8M |
| SLDBSolid Biosciences Inc. | 495,076 | $3.6M |
| ANTXAN2 Therapeutics, Inc. | 993,671 | $3.4M |
| TECXTectonic Therapeutic, Inc. | 100,000 | $3.1M |
| RLMDRELMADA THERAPEUTICS, INC. | 421,052 | $2.9M |
| TRDAEntrada Therapeutics, Inc. | 215,977 | $2.7M |
| NTLAIntellia Therapeutics, Inc. | 200,998 | $2.6M |
| BHVNBiohaven Ltd. | 300,389 | $2.5M |
| AGIOAGIOS PHARMACEUTICALS, INC. | 74,423 | $2.5M |
| RCKTRocket Pharmaceuticals Inc. | 641,222 | $2.3M |
| ACETAdicet Bio, Inc. | 313,124 | $2.1M |
| ATAIAtai Beckley N.V. | 600,000 | $2.1M |
| PLRXPLIANT THERAPEUTICS, INC. | 1,666,830 | $2.1M |
| RZLTRezolute, Inc. | 611,797 | $1.9M |
| FDMT4D Molecular Therapeutics, Inc. | 200,001 | $1.9M |
| NBPNovaBridge Biosciences | 700,000 | $1.7M |
| NGNENeurogene Inc. | 83,835 | $1.7M |
| STOKStoke Therapeutics, Inc. | 50,120 | $1.6M |
| CBIOCRESCENT BIOPHARMA, INC. | 74,000 | $1.4M |
| ALGSAligos Therapeutics, Inc. | 177,362 | $1.3M |
| HUMAHumacyte Inc. | 2,002,582 | $1.2M |
| KURAKura Oncology, Inc. | 145,704 | $1.2M |
| IMUXIMMUNIC, INC. | 967,152 | $1.1M |
| WHWKWhitehawk Therapeutics, Inc. | 281,497 | $971K |
| CMPSCOMPASS Pathways plc | 175,439 | $970K |
| BBOTBridgeBio Oncology Therapeutics, Inc. | 103,707 | $928K |
| LENZLENZ Therapeutics, Inc. | 100,000 | $915K |
| PROKPROKIDNEY CORP. | 500,000 | $895K |
| CADLCandel Therapeutics, Inc. | 156,700 | $768K |
| VYGRVoyager Therapeutics, Inc. | 193,984 | $749K |
| CNTXContext Therapeutics Inc. | 250,088 | $655K |
| ZNTLZentalis Pharmaceuticals, Inc. | 266,032 | $623K |
| KLRSKalaris Therapeutics, Inc. | 100,000 | $577K |
| QNCXQuince Therapeutics, Inc. | 5,200,000 | $527K |
| QNRXQuoin Pharmaceuticals, Ltd. | 79,582 | $525K |
| RNAAtrium Therapeutics Inc. | 28,845 | $386K |
| ESPREsperion Therapeutics, Inc. | 127,028 | $348K |
| FATEFATE THERAPEUTICS INC | 238,650 | $286K |
| AARDAardvark Therapeutics, Inc. | 72,429 | $273K |